{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:17:02Z","timestamp":1790947022351,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejca.2019.09.025","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T22:51:25Z","timestamp":1573426285000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma"],"prefix":"10.1016","volume":"124","author":[{"given":"M.L.","family":"Tas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.J.","family":"Reedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Karim-Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Dierselhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.A.","family":"van Eijkelenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Grotel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.J.M.","family":"Kraal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.L.","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.O.R.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.M.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.09.025_bib1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/MPH.0b013e3181bcc809","article-title":"Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database","volume":"31","author":"Hsieh","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.24095\/hpcdp.38.3.01","article-title":"Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992-2010)","volume":"38","author":"Xie","year":"2018","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"10.1016\/j.ejca.2019.09.025_bib3","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ejca.2006.05.014","article-title":"Time trends of cancer incidence in European children (1978-1997): report from the automated childhood cancer information system project","volume":"42","author":"Kaatsch","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The international neuroblastoma risk group (INRG) staging system: an INRG task force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (INRG) classification system: an INRG task force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S","article-title":"International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group","volume":"92","author":"Shimada","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib9","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib10","article-title":"High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma","author":"Yalcin","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2019.09.025_bib11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.1991.9.6.1050","article-title":"Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma","volume":"9","author":"Cheung","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.09.025_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.10859","article-title":"Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening","volume":"103","author":"Honjo","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib14","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/ijc.26315","article-title":"Progress against cancer in The Netherlands since the late 1980s: an epidemiological evaluation","volume":"130","author":"Karim-Kos","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/ijc.28990","article-title":"Cancer incidence, survival and mortality: explaining the concepts","volume":"135","author":"Ellis","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cas.13457","article-title":"Childhood cancer incidence and survival in Japan and England: a population-based study (1993-2010)","volume":"109","author":"Nakata","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2019.09.025_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa012277","article-title":"Neuroblastoma screening at one year of age","volume":"346","author":"Schilling","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.09.025_bib18","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/1097-0142(19951201)76:11<2363::AID-CNCR2820761127>3.0.CO;2-P","article-title":"Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project","volume":"76","author":"Takeuchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2188\/jea.JE20150054","article-title":"Effects of the cessation of mass screening for neuroblastoma at 6 Months of age: a population-based study in Osaka, Japan","volume":"26","author":"Ioka","year":"2016","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ejca.2019.09.025_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMoa012387","article-title":"Screening of infants and mortality due to neuroblastoma","volume":"346","author":"Woods","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.09.025_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canep.2016.03.015","article-title":"Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011","volume":"42","author":"Karim-Kos","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2019.09.025_bib22","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1200\/JCO.2003.10.168","article-title":"Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors","volume":"21","author":"Kerbl","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib23","series-title":"International classification of diseases for Oncology","author":"Fritz","year":"2000"},{"key":"10.1016\/j.ejca.2019.09.025_bib24","series-title":"International Classification of diseases for Oncology (ICD-O)","author":"WHO","year":"2013"},{"key":"10.1016\/j.ejca.2019.09.025_bib25","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"2002"},{"key":"10.1016\/j.ejca.2019.09.025_bib26","series-title":"SEER summary staging manual-2000: codes and coding instructions","year":"2001"},{"key":"10.1016\/j.ejca.2019.09.025_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejca.2009.09.011","article-title":"Childhood cancer mortality in Europe, 1970-2007","volume":"46","author":"Bosetti","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib28","first-page":"126","article-title":"Cancer registration: principles and methods. Statistical methods for registries","author":"Boyle","year":"1991","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.ejca.2019.09.025_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001-10: a population-based registry study","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib30","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ejca.2006.05.008","article-title":"Neuroblastoma incidence and survival in European children (1978-1997): report from the automated childhood cancer information system project","volume":"42","author":"Spix","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjc.6604922","article-title":"Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981-2000: a population-based study","volume":"100","author":"Schroeder","year":"2009","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2019.09.025_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40272-017-0251-3","article-title":"Incidence, survival, and treatment of localized and metastatic neuroblastoma in Germany 1979-2015","volume":"19","author":"Berthold","year":"2017","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ejca.2019.09.025_bib33","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejca.2019.09.025_bib34","first-page":"83","article-title":"Childhood and adolescent cancer statistics","volume":"64","author":"Ward","year":"2014","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejca.2019.09.025_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.30482","article-title":"The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: a descriptive study","volume":"140","author":"Shinagawa","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib36","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/0959-8049(95)00355-M","article-title":"Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries","volume":"31A","author":"van der Sanden","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.09.025_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","article-title":"Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial","volume":"6","author":"Berthold","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.09.025_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2407-11-21","article-title":"Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy","volume":"11","author":"Simon","year":"2011","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejca.2019.09.025_bib39","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ejca.2006.05.013","article-title":"Geographical comparison of cancer survival in European children (1988-1997): report from the automated childhood cancer information system project","volume":"42","author":"Sankila","year":"2006","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919307518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919307518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:25:51Z","timestamp":1760732751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919307518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":39,"alternative-id":["S0959804919307518"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.09.025","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}